CompletedNCT01188265
Dextromethorphan Added to Valproate for Bipolarity
Medication studyAges 18–65Taiwan
Understand this study
Who was this study for?
This study was for people with bipolarity. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.
- Listed locations
- TainanSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
Study start dateJune 2007
- Recruitment status
- Completed
- Enrollment listed in the registry
- 300
- Sponsor
- National Cheng-Kung University Hospital
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- Taiwan
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT01188265
- Official title
Show the full official title
Dextromethorphan Enhances the Therapeutic Efficacy of Valoproate in Bipolar Disorder Patients
Get this study by email
Recruitment & locations
CompletedTainan
Questions about this study
Who is behind this study?
The study sponsor is National Cheng-Kung University Hospital, a hospital or academic medical center.
Did this study involve medication?
Yes. The study involved medication, including valproate, Dextromethorphan 60 mg per day, Placebo and Dextromethorphan 30 mg.
Who was this study for?
This study was for people with bipolarity. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.
